NCT04517318已完成不适用
A Multi-center Study of the Treatment Patterns and Clinical Outcomes of Subsequent Therapies After Progression on Palbociclib in HR+/HER2- Metastatic Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- PFS
研究概览
简要总结
To evaluate the prescription patterns and treatment outcomes of subsequent therapies after progression on palbociclib in the real world.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •woman, age > 18 years old
- •Diagnosed with HR+/HER2- Metastatic Breast Cancer
- •Patients received at least one-cycle next-line treatment after progression on combined palbociclib and endocrine therapy
- •Complete medical history was available
排除标准
- •Medical history was incomplete
结局指标
主要结局
PFS
时间窗: 6 weeks
Progression free survival
Adverse events
时间窗: 6 weeks
Number of participants with treatment-related adverse events as assessed by Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v4.0)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System TuberculosisCentral Nervous System TuberculosisNCT06011915Tongji Hospital638
进行中（未招募）
不适用
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis PatientsTuberculosisNCT06021041Tongji Hospital900
已完成
不适用
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in BelgiumCarcinoma, Non-Small-Cell LungNCT03761901AstraZeneca141
已完成
不适用
Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:Lung CancerNCT04836975AstraZeneca45
已完成
不适用
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)Breast CancerNCT01615068Genentech, Inc.1,007